16 Oct 25
Welcome to tranScrip’s monthly newsletter where we share with you the latest news and views from across the organisation. This edition includes:
A message from our Chief Executive Officer
Dear Readers,
I’m pleased to welcome you to May’s edition of the tranScrip newsletter.
This month’s insights reflect the breadth of our expertise and the power of early, strategic thinking. Our feature on building effective Market Access strategies highlights just how critical it is to plan with the end in mind, not just for successful launches, but for long-term patient and commercial impact. Similarly, our recent collaboration with the BIA to launch their new regulatory and access community reinforces the importance of collective action to accelerate innovation and strengthen the UK’s position in global healthcare development.
We’re also delighted to announce that Roz Sutton has been appointed SVP Head of Regulatory, leading our Regulatory Business Unit. Roz brings a wealth of experience and leadership to the role, and we’re excited about the continued growth, development and continuing gold standard support for our clients from our regulatory team under her guidance.
As always, we’re looking ahead. Our teams are preparing for key global events including ASCO and BIO International, where we look forward to reconnecting with clients, partners, and peers. If you’re attending, we’d love to hear from you.
Thank you for continuing to be part of the tranScrip community.
Warm regards,
Mark Corbett
Chief Executive Officer
tranScrip Appoints Roz Sutton as Head of Regulatory
tranScrip is pleased to announce that Roz Sutton will be heading up our Regulatory Affairs Business Unit. This appointment reflects tranScrip’s commitment to strengthening our leadership team across core areas of the business and our continued focus on delivering expert-led regulatory solutions to clients around the world.
Roz brings over 20 years of experience in Global Regulatory Affairs, including senior roles at Roche and GSK, as well as regulatory consultancy experience at DLRC. Since joining tranScrip, she has led numerous complex regulatory programmes across a wide range of therapeutic areas, playing a key role in expanding and enhancing our regulatory services to meet the evolving demands of the pharmaceutical and biotech sectors.
Mark Corbett, Chief Executive Officer at tranScrip, commented: “We are thrilled to have Roz lead our Regulatory Affairs Business Unit. Her deep regulatory expertise and client-focused mindset make her ideally placed to take this part of our business forward. As tranScrip continues to grow, strengthening our leadership across all functions ensures we remain at the forefront of delivering integrated and high-quality drug development support.”
5 Essentials for Building a Market Access Strategy That Delivers
Market Access isn’t just about launch; it’s about long-term value.
For biotech and pharma companies, early strategic planning can mean the difference between success and setback. From embedding access early to adapting global plans locally, we outline five essentials for building smarter Market Access strategies.
Read more > https://transcrip-group.com/resources/5-essentials-for-building-a-market-access-strategy-that-delivers/
Insights from the BIA & tranScrip Regulatory Webinar: Regulatory and Access Community Connects
BioIndustry Association (BIA) and tranScrip hosted a webinar to launch the BIA regulatory and access community, this webinar focused on how this new community can help drive the growth of the UK healthcare economy by supporting innovation, collaboration, and strategic regulatory planning.
Roz Sutton delivered an insightful presentation on the rapidly evolving regulatory and market access landscape, highlighting innovative UK tools and processes that:
- Champion the UK as a unique and critical part of global development strategies
- Encourage collaboration across patients, developers, regulators, payers, and HCPs
- Embrace innovation through frameworks like iLAP and adaptive trial approaches
Louise Knowles (MHRA) shared valuable updates on:
- The relaunched iLAP
- Decentralised supply chains
- The streamlines UK CTA framework
The panel discussion with Gwenaelle Pemberton and Rosemarie Delaney PhD explored:
- The importance for developers to engage early
- Barriers to study start-up in the NHS
- The urgent need for tools like a UK-wide recruitment database and enhanced genomic testing
– Market access strategies and early planning considerations
A key takeaway: Start-ups and SMEs navigating the complex UK regulatory and market access environment don’t have to go it alone. Communities like this one and expert consultancies, like tranScrip, are here to help.
Upcoming Conferences and Events
Rob Fox will be attending ASCO 2025, one of the largest and most influential oncology meetings in the world. With cutting-edge science, breakthrough data, and global networking opportunities, it’s a key moment in the oncology calendar.
If you’re heading to Chicago, we’d love to schedule a meeting > contact us
Rob Fox and Inigo Montes will be attending this year’s BIO International Convention in Boston, 16-19 June.
If you’re attending BIO, we’d love to connect. Whether it’s to explore potential collaborations, share insights, or simply catch up, reach out via the partnering platform to schedule a meeting > BIO Partnering
Not attending BIO but based in the Boston area? We’d still love to meet, get in touch here > contact us
Thank you for reading this month’s edition of tranScrip’s newsletter. Feel free to share your feedback in the comments.
To learn more about how we can support you, contact us.
Best regards, The tranScrip Team
Our experienced physicians and scientists, together with our regulatory, clinical and commercial experts can support you to maximise the value of your products. Whatever your project requires, we have the expertise to meet your needs.
